• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗方式与肝内胆管细胞癌患者切缘状态和总体生存的相关性。

Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.

机构信息

Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.

Newton Wellesley Hospital, Newton, MA, USA.

出版信息

Ann Surg Oncol. 2019 Nov;26(12):4091-4099. doi: 10.1245/s10434-019-07657-5. Epub 2019 Jul 31.

DOI:10.1245/s10434-019-07657-5
PMID:31368018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6788972/
Abstract

BACKGROUND

Many studies have demonstrated associations between surgical resections at academic centers and improved outcomes, particularly for complex operations. However, few studies have examined this relationship in intrahepatic cholangiocarcinoma (ICC). The hypothesis of this study was that facility type is associated with improved postoperative outcomes and survival for patients with ICC who undergo resection.

METHODS

Patients with stages 1 to 3 ICC who underwent hepatectomy were identified using the National Cancer Database (NCDB) (2004-2014). Facilities were categorized as academic or community centers per Commission on Cancer designations. High-volume hospitals were those that performed 11 or more hepatectomies per year. Multilevel logistic mixed-effects models to identify predictors of outcomes and parametric survival-time models were used to determine overall survival (OS).

RESULTS

The study identified 2256 patients. Of these patients, 423 (18.8%) were treated at community centers, and 1833 (81.3%) were treated at academic centers. Nearly all high-volume centers were academic facilities (98.5% academic vs. 1.5% community centers), whereas low-volume centers were mixed (65.5% academic vs. 34.5% community centers) (p < 0.001). Surgery performed at an academic center was an independent predictor of decreased positive margins (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.51-0.98; p = 0.04), a lower 90-day mortality rate (OR, 0.62; 95% CI, 0.39-0.97; p = 0.03), and improved OS (hazard ratio [HR], 0.78; 95% CI, 0.63-0.96; p = 0.02). Facility hepatectomy volume was not independently associated with any short- or long-term outcomes.

CONCLUSIONS

Treatment at an academic center is associated with fewer positive resection margins, a decreased 90-day mortality rate, and improved OS for patients who undergo ICC resection. Facility surgical volume was not shown to be significantly associated with any postoperative outcomes after adjustment for patient and disease characteristics.

摘要

背景

许多研究表明,在学术中心进行手术切除与改善结果之间存在关联,尤其是对于复杂手术。然而,很少有研究在肝内胆管癌 (ICC) 中检查这种关系。本研究的假设是,对于接受肝切除术的 ICC 患者,机构类型与术后结果和生存改善有关。

方法

使用国家癌症数据库 (NCDB)(2004-2014 年)确定 I 期至 III 期 ICC 患者。根据癌症委员会的指定,将机构分为学术或社区中心。高容量医院是指每年进行 11 次或更多次肝切除术的医院。使用多水平逻辑混合效应模型来识别结果的预测因素,并使用参数生存时间模型来确定总体生存率 (OS)。

结果

本研究共纳入 2256 名患者。其中,423 名(18.8%)在社区中心治疗,1833 名(81.3%)在学术中心治疗。几乎所有高容量中心都是学术机构(98.5%为学术机构,1.5%为社区中心),而低容量中心则混合存在(65.5%为学术机构,34.5%为社区中心)(p<0.001)。在学术中心进行手术是降低阳性切缘(优势比 [OR],0.71;95%置信区间 [CI],0.51-0.98;p=0.04)、降低 90 天死亡率(OR,0.62;95%CI,0.39-0.97;p=0.03)和改善 OS(风险比 [HR],0.78;95%CI,0.63-0.96;p=0.02)的独立预测因素。机构肝切除术量与任何短期或长期结果均无独立关联。

结论

在学术中心治疗与 ICC 切除患者的更少阳性切缘、降低 90 天死亡率和改善 OS 相关。在调整患者和疾病特征后,机构手术量与任何术后结果均无显著关联。

相似文献

1
Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.治疗方式与肝内胆管细胞癌患者切缘状态和总体生存的相关性。
Ann Surg Oncol. 2019 Nov;26(12):4091-4099. doi: 10.1245/s10434-019-07657-5. Epub 2019 Jul 31.
2
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.美国肝内胆管癌患者的发病率、治疗方法和结局的变化趋势:医疗机构类型与切缘状态、淋巴结清扫术的应用和总体生存率有关。
World J Surg. 2019 Jul;43(7):1777-1787. doi: 10.1007/s00268-019-04966-4.
3
Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma.肝内胆管癌手术后切缘长度的预后价值。
Am J Surg. 2021 Aug;222(2):383-389. doi: 10.1016/j.amjsurg.2020.12.022. Epub 2020 Dec 15.
4
Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.原发性肝癌:NCDB 分析肝切除术后总生存率和切缘情况。
Ann Surg Oncol. 2020 Apr;27(4):1156-1163. doi: 10.1245/s10434-019-07843-5. Epub 2019 Nov 1.
5
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.确定肝内胆管癌切除术后辅助治疗的益处。
Ann Surg Oncol. 2015 Jul;22(7):2209-17. doi: 10.1245/s10434-014-4275-4. Epub 2014 Dec 5.
6
Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.外科治疗集中化趋势与国家癌症中心网络切除性胆管癌治疗指南的遵循情况。
HPB (Oxford). 2019 Aug;21(8):981-989. doi: 10.1016/j.hpb.2018.11.013. Epub 2018 Dec 25.
7
The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience.肝内胆管癌患者手术切缘宽度的影响:单中心经验
Medicine (Baltimore). 2016 Jul;95(28):e4133. doi: 10.1097/MD.0000000000004133.
8
Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.根治性切除术后肝内胆管细胞癌的复发模式和时间进程。
Ann Surg Oncol. 2019 Aug;26(8):2549-2557. doi: 10.1245/s10434-019-07353-4. Epub 2019 Apr 24.
9
Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.解剖性与非解剖性肝切除术对肝内胆管细胞癌患者短期和长期结局的影响。
Ann Surg Oncol. 2019 Jun;26(6):1841-1850. doi: 10.1245/s10434-019-07260-8. Epub 2019 Mar 6.
10
Prognostic value of positive surgical margins after resection of cholangiocarcinoma. Experience at a high-volume hospital center specializing in hepatopancreatobiliary surgery.胆管癌切除术后切缘阳性的预后价值。一家专注于肝胆胰外科的大型医院中心的经验。
Rev Gastroenterol Mex (Engl Ed). 2020 Jan-Mar;85(1):18-24. doi: 10.1016/j.rgmx.2018.11.011. Epub 2019 Nov 1.

引用本文的文献

1
Care Patterns and Outcomes for Intrahepatic Cholangiocarcinoma by Rurality of Patient Residence in a Midwestern State.美国中西部某州患者居住地的乡村属性对肝内胆管癌护理模式及预后的影响
J Surg Oncol. 2025 Mar;131(3):450-456. doi: 10.1002/jso.27939. Epub 2024 Oct 4.
2
The impact of facility type on surgical outcomes in colon cancer patients: analysis of the national cancer database.医疗机构类型对结肠癌患者手术结局的影响:国家癌症数据库分析
Surg Endosc. 2024 Dec;38(12):7503-7511. doi: 10.1007/s00464-024-11230-x. Epub 2024 Sep 13.
3
Impact of Adjuvant Radiotherapy Setting on Quality-of-Life in Head and Neck Squamous Cell Carcinoma.辅助放疗环境对头颈部鳞状细胞癌患者生活质量的影响
Laryngoscope. 2024 Aug;134(8):3645-3655. doi: 10.1002/lary.31382. Epub 2024 Mar 4.
4
Surgical Aspects of Intrahepatic Cholangiocarcinoma.肝内胆管癌的外科手术相关方面
Cancers (Basel). 2022 Dec 19;14(24):6265. doi: 10.3390/cancers14246265.
5
Defining Facility Volume Threshold for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Resection of Perihilar Cholangiocarcinoma.确定肝门部胆管癌切除患者短期和长期预后优化的手术量阈值
J Gastrointest Surg. 2023 Apr;27(4):730-740. doi: 10.1007/s11605-022-05465-z. Epub 2022 Sep 22.
6
Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach.优化肝内胆管癌患者的诊断和生物标志物检测:一种多学科方法。
Cancers (Basel). 2022 Jan 13;14(2):392. doi: 10.3390/cancers14020392.
7
Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database.纤维肉瘤的原发部位及其他预后因素:一项基于国家癌症数据库的分析
Cureus. 2021 Oct 31;13(10):e19163. doi: 10.7759/cureus.19163. eCollection 2021 Oct.
8
Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period.肝内胆管癌的肝切除术——单中心13年期间286例接受手术探查患者的经验
J Clin Med. 2021 Aug 13;10(16):3559. doi: 10.3390/jcm10163559.
9
The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.治疗设施类型对脑转移瘤患者生存的影响,与原发癌类型无关。
BMC Cancer. 2021 Apr 9;21(1):387. doi: 10.1186/s12885-021-08129-4.
10
Surgical management of biliary malignancy.胆管恶性肿瘤的外科治疗
Curr Probl Surg. 2021 Feb;58(2):100854. doi: 10.1016/j.cpsurg.2020.100854. Epub 2020 Jun 30.

本文引用的文献

1
Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.外科治疗集中化趋势与国家癌症中心网络切除性胆管癌治疗指南的遵循情况。
HPB (Oxford). 2019 Aug;21(8):981-989. doi: 10.1016/j.hpb.2018.11.013. Epub 2018 Dec 25.
2
Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates.肝内胆管癌:美国癌症联合委员会/国际抗癌联盟第8版更新内容
Chin Clin Oncol. 2018 Oct;7(5):52. doi: 10.21037/cco.2018.07.03. Epub 2018 Jul 12.
3
Challenges of surgical management of intrahepatic cholangiocarcinoma.肝内胆管细胞癌的外科治疗挑战。
Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):671-681. doi: 10.1080/17474124.2018.1489229. Epub 2018 Jun 27.
4
Practical Guide to Surgical Data Sets: National Cancer Database (NCDB).《手术数据集实用指南:国家癌症数据库(NCDB)》
JAMA Surg. 2018 Sep 1;153(9):850-851. doi: 10.1001/jamasurg.2018.0492.
5
Dutch surgeons' views on the volume-outcome mechanism in surgery: A qualitative interview study.荷兰外科医生对手术中容量-结果机制的看法:一项定性访谈研究。
Int J Qual Health Care. 2017 Oct 1;29(6):797-802. doi: 10.1093/intqhc/mzx100.
6
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.肝内胆管癌的全身治疗和辅助治疗
Cancer Control. 2017 Jul-Sep;24(3):1073274817729241. doi: 10.1177/1073274817729241.
7
Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.胰腺腺癌胰十二指肠切除术后医院类型对生存结局的影响。
HPB (Oxford). 2017 Dec;19(12):1046-1057. doi: 10.1016/j.hpb.2017.04.017. Epub 2017 Sep 28.
8
Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base.在学术癌症中心和社区癌症中心切除腹膜后肉瘤后的总生存:国家癌症数据库分析。
Surgery. 2018 Feb;163(2):318-323. doi: 10.1016/j.surg.2017.07.009. Epub 2017 Sep 21.
9
Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy.容积承诺对空间可及性的潜在影响:对接受胰腺切除术患者的人群水平分析。
Surgery. 2017 Aug;162(2):203-210. doi: 10.1016/j.surg.2017.03.010. Epub 2017 May 11.
10
Using the National Cancer Database for Outcomes Research: A Review.利用国家癌症数据库进行结果研究:综述。
JAMA Oncol. 2017 Dec 1;3(12):1722-1728. doi: 10.1001/jamaoncol.2016.6905.